Literature DB >> 17163344

Comparison between transuncal approach and upper vertebral transcorporeal approach for unilateral cervical radiculopathy - a preliminary report.

W J Hong1, W K Kim, C W Park, S G Lee, C J Yoo, Y B Kim, H D Jho.   

Abstract

OBJECTIVE: The surgical treatments for unilateral cervical radiculopathy have been performed by either the anterior or posterior approach. The anterior approach has usually been used more than the posterior approach. The authors compared the results of newly advanced upper vertebral transcorporeal (UVTC) approach with those of the original transuncal (TU) approach in the anterior approach.
METHODS: The anterior cervical microforaminotomy was performed for 60 patients (male:female=40:20) from June, 2000 to October, 2003. 40 patients were treated by the TU approach while 20 patients were operated on by the new UVTC approach. The authors analyzed postoperative changes of disc height, the spinal instability, the average length of hospital stay, the degree of patients' satisfaction and complications from each approach. The mean follow-up period was 9.5 months.
RESULTS: In the TU approach, postoperative intervertebral disc height was decreased from 7.1+/-0.65 mm to 6.2+/-0.61 mm. In the UVTC approach, postoperative intervertebral disc height was decreased from 6.6+/-0.43 mm to 6.3+/-0.41 mm. The average length of hospital stay was 5.2 days for the TU approach and 3.4 days for the UVTC approach. In the TU approach, 28 patients experienced excellent results, 11 patients experienced good results, one patient who experienced a fair result was operated by anterior cervical fusion because of a recurrent herniated disc. In the UVTC approach, 16 patients had excellent results and four patients experienced good results.
CONCLUSIONS: This comparative study demonstrates that the UVTC approach is a better surgical technique than the TU approach considering the preservation of disc height, spinal stability, length of hospital stay, degree of satisfaction and complications.

Entities:  

Mesh:

Year:  2006        PMID: 17163344     DOI: 10.1055/s-2006-954828

Source DB:  PubMed          Journal:  Minim Invasive Neurosurg        ISSN: 0946-7211


  7 in total

1.  Inferiorly migrated disc fragment at t1 body treated by t1 transcorporeal approach.

Authors:  Byung Kwan Choi; In Ho Han; Won Ho Cho; Seung Heon Cha
Journal:  J Korean Neurosurg Soc       Date:  2011-01-31

Review 2.  Minimally invasive spine surgery: systematic review.

Authors:  Péter Banczerowski; Gábor Czigléczki; Zoltán Papp; Róbert Veres; Harry Zvi Rappaport; János Vajda
Journal:  Neurosurg Rev       Date:  2014-09-10       Impact factor: 3.042

3.  [Clinical study of single-level cervical disc herniation treated by full-endoscopic decompression via anterior transcorporeal approach].

Authors:  Junsong Yang; Lei Chu; Zhongliang Deng; Liu Kai-Xuan; Rui Deng; Hao Chen; Peng Liu; Tuanjiang Liu; Xueqin Rong; Dingjun Hao
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2020-05-15

4.  Extent of disc degeneration after single-level cervical anterior microforaminotomy analyzed with long-term radiological data.

Authors:  Chul Han; Myung-Hyun Kim
Journal:  J Korean Neurosurg Soc       Date:  2014-09-30

5.  Percutaneous full-endoscopic anterior transcorporeal cervical discectomy and channel repair: a technique note report.

Authors:  Qian Du; Lan-Qiong Lei; Guan-Ru Cao; Wei-Jun Kong; Jun Ao; Xin Wang; An-Su Wang; Wen-Bo Liao
Journal:  BMC Musculoskelet Disord       Date:  2019-06-10       Impact factor: 2.362

6.  Early outcome of posterior cervical endoscopic discectomy: an alternative treatment choice for physically/socially active patients.

Authors:  Chi Heon Kim; Chun Kee Chung; Hyun Jib Kim; Tae Ahn Jahng; Dong Gyu Kim
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

7.  Microdiscectomy and Foraminotomy in Cervical Spondylotic Myelopathy and Radiculopathy.

Authors:  Toshiyuki Okazaki; Hiroshi Nakagawa; Hideo Mure; Kenji Yagi; Hitoshi Hayase; Yasushi Takagi; Koji Saito
Journal:  Neurol Med Chir (Tokyo)       Date:  2018-10-06       Impact factor: 1.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.